‘I understood what women have been going through’

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Financial Intelligence • Markets • World News • Independent Analysis
Published: 2026-09-22 • Permanent link

Rumors of a substantial price tag surrounding Gemini Robotics' ER 2 humanoid robot have been circulating, with some speculating that the cost exceeds $1 million. Industry insiders claim the ER 2 boasts advanced features, including enhanced dexterity and improved cognitive abilities. The news has sent shockwaves through the tech community, with many questioning the viability of such a pricey robot. As a result, investors are reevaluating their involvement in the company.

As this controversy gains traction, it's essential to consider the broader implications. For investors, the ER 2's high price tag poses significant risks, potentially resulting in substantial losses. Moreover, the hefty cost could limit the robot's adoption, hindering Gemini Robotics' growth prospects. This, in turn, could have far-reaching consequences for the robotics industry as a whole.

Gemini Robotics' ER 2 is not an isolated case. The company's predecessors, such as the humanoid robot developed by Honda, have also faced challenges related to cost and practicality. Historically, significant advancements in robotics have been driven by government funding and collaborations with academia. However, the current market dynamics are different, with a greater emphasis on private investment and commercial viability.

The fallout from the ER 2's price tag is likely to be significant, with investors and analysts scrutinizing Gemini Robotics' financials closely. As the company navigates this challenging period, it will be crucial to demonstrate the value proposition of the ER 2 and address concerns regarding its cost. A successful outcome will depend on Gemini Robotics' ability to balance innovation with commercial viability, a delicate balancing act that will be closely watched by the industry.